Advertisement

Topics

Forest Laboratories, Inc. and Almirall, S.A. Company Profile

17:38 EDT 23rd September 2018 | BioPortfolio

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-established central nervous system and cardiovascular franchises and innovations in anti-infective, respiratory, gastrointestinal and pain management medicine. Forest’s pipeline, the most robust in its history, includes product candidates in all stages of development across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more, visit www.FRX.com.


News Articles [428 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

Almirall Acquires Allergan Dermatology Products for $550M

Expands Almirall's presence in the U.S. through their manufacturing subsidiary Aqua Pharmaceuticals

Almirall up 4% as 1st-qtr results hint at better times

Shares in Almirall closed 4% up on Monday at 10.60 euros after Spain’s biggest drugmaker revealed its…

Almirall's chronic plaque psoriasis drug approved in EU

Almirall's Ilumetri, or tildrakizumab, subcutaneous injection was approved by the European Commission as a treatment for adul -More- 

Allergan sells off dermatology drugs to Spain's Almirall

Almirall will pay $550 million in cash to bring the five drugs on board and anticipates the deal will be immediately accretive to earnings. 

Almirall's Ilumetri scores EU approval in chronic plaque psoriasis http://bit.ly/2xxdNor  #Almirall #EU #PlaquePsoriasispic.twitter.com/YBb0sR5ny3

Almirall's Ilumetri scores EU approval in chronic plaque psoriasis http://bit.ly/2xxdNor  #Almirall #EU #PlaquePsoriasis pic.twitter.com/YBb0sR5ny3

Almirall picks up Allergan's dermatology portfolio to for $650m

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 million in cash. The deal breaks down to an upfront cash payment ...

Kooperationsmeister Evotec: Neuer Deal mit Almirall - Attacke auf Mehrjahreshoch

Der deutsche Wirkstoffforscher Evotec hat eine Allianz im Bereich Hautkrankheiten mit dem spanischen Pharma-Konzern Almirall geschlossen. Wie die Hamburger mitteilten, sollen im Rahmen der Kooperat...

PubMed Articles [551 Associated PubMed Articles listed on BioPortfolio]

Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies.

Laboratory Safety in Parasitology Laboratory.

Working in a laboratory is very difficult and needs special attention. Laboratory workers can be exposed to numerous potential hazards including chemical, biological, physical, and radioactive. That i...

Moisture content estimation of forest litter based on remote sensing data.

As a fine fuel, forest litter plays an important role in fire danger rating systems, so forest litter moisture data are necessary and meaningful for fire risk management and prevention. An optical rem...

Global patterns of tropical forest fragmentation.

Remote sensing enables the quantification of tropical deforestation with high spatial resolution. This in-depth mapping has led to substantial advances in the analysis of continent-wide fragmentation ...

Leaching of natural colloids from forest topsoils and their relevance for phosphorus mobility.

The leaching of P from the upper 20cm of forest topsoils influences nutrient (re-)cycling and the redistribution of available phosphate and organic P forms. However, the effective leaching of colloids...

Clinical Trials [291 Associated Clinical Trials listed on BioPortfolio]

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1040 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc. and Almirall, S.A.

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-esta...

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Almirall Ltd

Almirall, an international pharmaceutical company is based on innovation and committed to health. Headquartered in Barcelona, Spain, the company researches, develops, manufactures and commercialis...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Forest Laboratories, Inc. and Almirall, S.A." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. and Almirall, S.A. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. and Almirall, S.A. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. and Almirall, S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. and Almirall, S.A. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. and Almirall, S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record